RTTNews | Jul 22, 2021 07:44AM EDT

07:44 Thursday, July 22, 2021 (RTTNews.com) - While reporting financial results for the second quarter on Thursday, Abbott Laboratories (ABT) maintained its earnings and adjusted earnings guidance for the full-year 2021, which was slashed in early June due to significantly lower recent and projected COVID-19 diagnostic testing demand. For fiscal 2021, the company continues to project earnings from continuing operations in a range of $2.75 to $2.95 per share and adjusted earnings from continuing operations in a range of $4.30 to $4.50 per share, reflecting strong double-digit growth from last year.

On average, 21 analysts polled by Thomson Reuters expect the company to report earnings of $4.36 per share for the year. Analysts' estimates typically exclude special items.

On June 11, 2021, the board of directors of Abbott declared the company's quarterly cash dividend of $0.45 per share, payable on August 16, 2021 to shareholders of record at the close of business on July 15, 2021.

Read the original article on RTTNews ( https://www.rttnews.com/3211098/abbott-laboratories-maintains-fy21-outlook-quick-facts.aspx)

For comments and feedback: contact editorial@rttnews.com

Copyright(c) 2021 RTTNews.com All Rights Reserved